Education and Mentorship

Dr. Chovatiya educates healthcare providers, patients, and industry partners nationally and internationally at major conferences and meetings. His lectures are primarily focused on contextualizing immunology that underlies chronic skin disease and translating this knowledge toward better understanding of disease pathogenesis, burden, and treatment. Selected lectures from recent meetings include:

2024

1. June 10, 2024. “Impact of amlitelimab (an anti-OX40 Ligand antibody) on Clinical Outcome Assessments for atopic dermatitis: results from the 52-week STREAM-AD phase 2b study in adults with moderate-to-severe atopic dermatitis.” Late-Breaking Research. Revolutionizing Atopic Dermatitis Conference, Chicago, IL.
2. June 10, 2024. “Patient Preferences for Atopic Dermatitis Treatment Profiles: Results from A Discrete Choice Experiment.” Late-Breaking Research. Revolutionizing Atopic Dermatitis Conference, Chicago, IL.
3. June 10, 2024. “United States Prevalence of Atopic Dermatitis in Adults by Race and Ethnicity.” Late-Breaking Research. Revolutionizing Atopic Dermatitis Conference, Chicago, IL.
4. June 10, 2024. “Raising the bar of efficacy in atopic dermatitis: lebrikizumab maintains depth of response over 2 years.” Late-Breaking Research. Revolutionizing Atopic Dermatitis Conference, Chicago, IL.
5. June 10, 2024. “The TCS/TCI-free rate remains high and stable while on lebrikizumab for treatment of moderate-to-severe atopic dermatitis over 1 year.” Late-Breaking Research. Revolutionizing Atopic Dermatitis Conference, Chicago, IL.
6. June 10, 2024. “Can We Achieve Remission with Our Current Therapies?” Revolutionizing Atopic Dermatitis Conference, Chicago, IL.
7. June 10, 2024. “What’s New in Itch Therapy: How Do Approved Therapies Stack Up?” Revolutionizing Atopic Dermatitis Conference, Chicago, IL.
8. June 1, 2024. “Management of Chronic Hand Eczema: Hope on the Horizon.” Fall Clinical NP & PA 24, Scottsdale, AZ.
9. June 1, 2024. “Talking JAK: Patient Conversations and Best Practices.” Fall Clinical NP & PA 24, Scottsdale, AZ.
10. May 31, 2024. How Seb D Got Its Groove Back. Fall Clinical NP & PA 24, Scottsdale, AZ.
11. May 30, 2024. “Update in the treatment of atopic dermatitis: Exploring the concept of remission with systemic therapy.” Medical Dermatology Therapy Update III, Cleveland, OH.
12. May 4, 2024. “Eczematous Disorders in Adults and Children.” Board Immersion 2024, Virtual Conference.
13. April 27, 2024. “Neuroimmune Axis and Neuroinflammation in Prurigo Nodularis.” Dupi Xperience LATAM. Buenos Aires, Argentina.
14. April 27, 2024. “Exploring the Concept of Disease Modification in Atopic Dermatitis.” Dupi Xperience LATAM. Buenos Aires, Argentina.
15. April 23, 2024. “Chronic Hand Eczema: Putting the Pieces Together.” LearnSkin. National Webinar.
16. April 24, 2024. “Small Molecules Redefine the Control of Atopic Dermatitis.” Umer Doctor, China. Virtual Webinar.
17. April 16, 2024. “How to Be a Key Opinion Leader.” ClubDerm. National Webinar.
18. March 23, 2024. “Rapid Fire Dermatology.” Diversity in Dermatology Conference, San Antonio, TX.
19. March 23, 2024. “Life’s An Itch: Updates in Prurigo Nodularis.” Diversity in Dermatology Conference, San Antonio, TX.
20. March 11, 2024. “Itch Tales: Looking Beyond Atopic Dermatitis” Symposium Chair and Speaker. American Academy of Dermatology Annual Meeting, New Orleans, LA.
21. March 9, 2024. “Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making.” Symposium Chair and Speaker. American Academy of Dermatology Annual Meeting, San Diego, CA. https://www.gotoper.com/courses/hidradenitis-suppurativa-hs-deepening-foundations-of-knowledge-in-disease-pathogenesis-disease-severity-assessment-and-treatment-decision-making. 
22. March 8, 2024. “From Heterogeneity Comes New Insights: Exploring the Role of T Cells and OX40 in Atopic Dermatitis.” Amgen. American Academy of Dermatology Annual Meeting, San Diego, CA.
23. March 7, 2024. “The IL-17 Family: In a Crowded Field, How One Cytokine is Changing the Game.” Symposium Chair and Speaker. UCB. American Academy of Dermatology Annual Meeting, San Diego, CA.
24. February 16, 2024. “How Should I Use JAK Inhibitors in My Practice?” Winter Clinical Dermatology Conference – Miami 2024, Miami, FL.
25. February 10, 2024. “The Pathophysiology of Generalized Pustular Psoriasis and Evidence for Spesolimab.” Boehringer-Ingelheim. Spevigo National Seminar, Tokyo, Japan.
26. January 26, 2024. “Exceptional Eczematous Expertise.” Maui Derm Hawaii, Maui, HI.
27. January 26, 2024. “Challenging Cases.” Maui Derm Hawaii, Maui, HI.
28. January 24, 2024. “Hidradenititis Suppurativa Update 2024.” Maui Derm Hawaii, Maui, HI.
29. January 23, 2024. “Bimekizumab response maintenance to 48 weeks in patients with moderate to severe hidradenitis suppurativa: Pooled responder analysis from the phase 3, double-blind, placebo-controlled, randomised clinical trials BE HEARD I and II.” Late Breakers. Maui Derm Hawaii, Maui, HI.
30. January 13, 2024. “Biologics: A New Approach to Managing the ‘Itch-Scratch Cycle’ of Prurigo Nodularis.” Winter Clinical Dermatology Conference – Hawaii 2024, Honolulu, HI.
31. January 8, 2024. Oral JAK Inhibition as Treatment for Atopic Dermatitis: An Introduction to Abrocitinib. Pfizer, Inc. University Hospital Galway, Galway, Ireland.

2023

1. December 10, 2023. “Living the Cream with Atopic Dermatitis.” Revolutionizing Atopic Dermatitis Conference, Virtual Meeting
2. December 1, 2023. “Practical Considerations for Using Biologics in PN.”  Sanofi and Regeneron. ADVENT Forum 2023: Connecting the Dots – The Shared Pathophysiology in Diseases with Underlying Type 2 Inflammation. Madrid, Spain.
3. December 1, 2023. “Deep Dive on the Role of Inflammation in the Pathophysiology of PN.”  Sanofi and Regeneron. ADVENT Forum 2023: Connecting the Dots – The Shared Pathophysiology in Diseases with Underlying Type 2 Inflammation. Madrid, Spain.
4. December 1, 2023. “Updates in PN and CSU: Emerging Therapeutic Landscapes and Implications for Patient Management – Emerging Therapeutic Landscape and Implications for Patient Management in Prurigo Nodularis.”  Sanofi and Regeneron. ADVENT Forum 2023: Connecting the Dots – The Shared Pathophysiology in Diseases with Underlying Type 2 Inflammation. Madrid, Spain.
5. December 1, 2023. “Itch: The Common Thread in Dermatological Type 2 Inflammation – Neuroimmune Axis and Neuroinflammation in Prurigo Nodularis.”  Sanofi and Regeneron. ADVENT Forum 2023: Connecting the Dots – The Shared Pathophysiology in Diseases with Underlying Type 2 Inflammation. Madrid, Spain.
6. November 2, 2023. “Disorders of Hypo and Depigmentation.” Las Vegas Dermatology Symposium, Las Vegas, NV.
7. October 21, 2023. “Diving Below the Surface of Type 2 Inflammation in AD, PN, and CSU: Implications for Clinical Practice.” Sanofi. Fall Clinical Dermatology Conference 2023, Las Vegas, NV.
8. October 21, 2023. “What You Need to Know Now About JAK Inhibitors.” Fall Clinical Dermatology Conference 2023, Las Vegas, NV.
9. October 19, 2023. “Biologics: A New Approach to Managing the ‘Itch-Scratch Cycle’ of Prurigo Nodularis.” Fall Clinical Dermatology Conference 2023, Las Vegas, NV.
10. October 19, 2023. “Atopic Dermatitis: The Top Five Challenge.” Inflammatory Disease Symposium 2023, Las Vegas, NV.
11. October 19, 2023. “Immunology 101.” Inflammatory Disease Symposium 2023, Las Vegas, NV.
12. October 13, 2023. “The Reason is Clear: Targeting Minimal Disease Activity in Atopic Dermatitis.” AbbVie. European Academy of Dermatology and Venerology 2023 Annual Meeting, Berlin, Germany.
13. October 12, 2023. “Itch is Only the Beginning: Achieving Disease Control in Atopic Dermatitis and Prurigo Nodularis.” Sanofi and Regeneron. European Academy of Dermatology and Venerology 2023 Annual Meeting, Berlin, Germany.
14. September 30, 2023. “Challenging Cases.” Maui Derm NP+PA Fall 2023, Asheville, NC.
15. September 28, 2023. “Hot Topics in Inflammatory Disease.” Maui Derm NP+PA Fall 2023, Asheville, NC.
16. September 28, 2023. “Atopic Dermatitis Update 2023.” Maui Derm NP+PA Fall 2023, Asheville, NC.
17. September 28, 2023. “Contact Dermatitis vs. Something Else.” Maui Derm NP+PA Fall 2023, Asheville, NC.
18. September 20, 2023. “Head and Neck Dermatitis: A Challenging Regional Eczema.” George Washington University Dermatology Training, Chicago, IL.
19. September 20, 2023. “When is It AD? When is It Not?.” George Washington University Dermatology Training, Chicago, IL.
20. September 17, 2023. “Emerging Therapies for the Treatment of Psoriasis: An Introduction to Oral TYK2 Inhibition.” Bristol Myers Squibb. Hong Kong Society of Dermatology and Venereology Annual Meeting, Hong Kong, Hong Kong.
21. September 8, 2023. “Addressing Unmet Needs in Generalized Pustular Psoriasis.” Boehringer-Ingelheim. Spevigo Global Speaker Tour, Osaka, Japan.
22. September 7, 2023. “Addressing Unmet Needs in Generalized Pustular Psoriasis.” Boehringer-Ingelheim. Spevigo Global Speaker Tour, Tokyo, Japan.
23. August 24, 2023. “Hair Today, Hair Tomorrow: Updates in Alopecia Areata.” Illinois Society of Dermatology Physician Assistants Annual Midwest Dermatology Conference, Chicago, IL.
24. August 24, 2023. Oral JAK Inhibition as Treatment for Atopic Dermatitis: An Introduction to Abrocitinib. Pfizer, Inc. Mater Hospital, Dublin, Ireland.
25. August 18, 2023. “An Introduction to Atopic Dermatitis.” University of California Irvine Department of Dermatology Resident Lecture, Irvine, CA.
26. August 10, 2023. Oral JAK Inhibition as Treatment for Atopic Dermatitis: An Introduction to Abrocitinib. Pfizer, Inc. St. James Hospital, Dublin, Ireland.
27. July 27, 2023. “The Impact of Social Determinants of Health on Patients of Color with Atopic Dermatitis.” HMP Global. Perspectives in Atopic Dermatitis, Virtual Meeting.
28. July 7, 2023. “Chronic Kidney Disease Associated Pruritus.” Pruritus and Dysesthesias – Special Manifestations of Pruritus. Session Co-Chair. World Congress of Dermatology 2023, Singapore, Singapore.
29. June 21, 2023. “Masters Track: Contact Dermatitis and Eczema.” Maui Derm NP+PA Summer 2023, Colorado Springs, CO.
30. June 13, 2023. “Early Career Challenges.” Young MD Connect. Virtual Webinar.
31. July 6, 2023. “Charting a New Course in Prurigo Nodularis: Changing the Treatment Paradigm with Biologic Therapy.” Sanofi. World Congress of Dermatology 2023, Singapore, Singapore.
32. May 29, 2023. Oral JAK Inhibition as Treatment for Atopic Dermatitis: An Introduction to Abrocitinib. Pfizer, Inc. University Hospital Limerick, Limerick, Ireland.
33. May 21, 2023. Pharmacology of Commonly Used Drugs and Drug Delivery. Board Immersion 2023, Virtual Conference.
34. May 20, 2023. “Vitiligo: Bringing Pigment Back.” New Wave Dermatology Conference, St. Petersburg, FL.
35. May 13, 2023. “Social Media as an Educational Platform for Seborrheic Dermatitis.” Concurrent Mini-Symposium: Clinical Research – Sociobehavioral and Health Services Research. International Societies of Investigative Dermatology Meeting, Tokyo, Japan.
36. May 12, 2023. “Unraveling the Heterogeneity of Atopic Dermatitis: A Closer Look at Longitudinal Course.” ISID Platinum Symposium: Explore Our Future from Investigative Research in AA, AD and PsO. International Societies of Investigative Dermatology Meeting, Tokyo, Japan.
37. May 10, 2023. Unraveling the Heterogeneity of Atopic Dermatitis: A Closer Look at Longitudinal Course. Eli Lilly and Co. Lilly Atopic Dermatitis Roundtable Discussion, Tokyo, Japan.
38. May 9, 2023. Unraveling the Heterogeneity of Atopic Dermatitis: A Closer Look at Longitudinal Course. Eli Lilly and Co. Lilly Dermatology National Webinar, Tokyo, Japan.
39. May 9, 2023. Unraveling the Heterogeneity of Atopic Dermatitis: A Closer Look at Longitudinal Course. Eli Lilly and Co. Lebrikizumab University, Tokyo, Japan.
40. May 1, 2023. “What is the evidence for long-term control with current therapies?” Mini-Symposium 4: Achieving Long-Term Control of Atopic Dermatitis. Revolutionizing Atopic Dermatitis Conference, Washington, DC.
41. May 1, 2023. “Tips and Tricks for Managing Atopic Dermatitis”. Panelist. Revolutionizing Atopic Dermatitis Conference, Washington, DC.
42. April 27, 2023. “Advanced Insights for Patients with Psoriasis: Understanding the Latest Clinical Evidence and Shared Decision-Making Options.” Spring Managed Care Forum (NAMCP, AAMCN, AAIHDS). Orlando, FL.
43. April 13, 2023. “Taking a Closer Look at Atopic Dermatitis and the Eyes: What You Need to Know.” Foundation for Research and Education in Dermatology. Early Career Dermatologist Initiative, National Webinar.
44. April 6, 2023. “The Chronic Burden of Type 2 Inflammatory Disease.” Sanofi. ADVENT: Society of Dermatology Physician Assistants, National Webinar
45. March 19, 2023. “The Challenges of Diagnosing Atopic Dermatitis.” Focus Session Director. American Academy of Dermatology Annual Meeting, New Orleans, LA.
46. March 17, 2023. “Efficacy and Safety of Baricitinib for Inflammatory Disease.” Symposium Speaker. American Academy of Dermatology Annual Meeting, New Orleans, LA.
47. March 17, 2023. “JAK Inhibitors in Atopic Dermatitis.” Symposium Speaker. American Academy of Dermatology Annual Meeting, New Orleans, LA.
48. March 17, 2023. “When Self-Identity Is Challenged in Dermatology: Clinical Implications for Alopecia Areata & Vitiligo.” Pfizer, Inc. American Academy of Dermatology Annual Meeting, New Orleans, LA.
49. March 9, 2023. “An Overview of Prurigo Nodularis.” Sanofi. ADVENT: Society of Dermatology Physician Assistants, National Webinar
50. March 2, 2023. “How to Confidently Read & Interpret Phase 3 Clinical Trials.” Diversity in Dermatology Conference, Orlando, FL.
51. March 2, 2023. “The Evolving Future of Vitiligo.” Diversity in Dermatology Conference, Orlando, FL.
52. March 2, 2023. “Atopic Dermatitis – Pediatric, Immunology, and Dermatology Viewpoints.” Diversity in Dermatology Conference, Orlando, FL.
53. February 28, 2023. “The Journey of Atopic Dermatitis.” Dermavant. Virtual Webinar.
54. February 18, 2022. “Early Career Dermatology Tips and Tricks.” Panelist. Winter Clinical Dermatology Conference – Miami, Miami, FL.
55. February 18, 2023. “Applying JAKs for the Treatment of Alopecia Areata.” Winter Clinical Dermatology Conference – Miami, Miami, FL.
56. February 16, 2023. “Notalgia Parasthetica: Background.” Cara Therapeutics. Capital Markets Day, New York, NY.
57. February 16, 2023. “Atopic Dermatitis: Segmenting the Market.” Cara Therapeutics. Capital Markets Day, New York, NY.
58. January 27, 2023. “Exceptional Eczematous Expertise and Powerful Patch Testing.” Maui Derm 2023, Maui, HI.
59. January 16, 2023. “Liberating Patients from Prurigo Nodularis One Itch at a Time.” Winter Clinical Dermatology Conference – Hawaii, Hawaii, HI.
60. January 14, 2023. “Anti-Inflammatory Disease Panel”. Winter Clinical Dermatology Conference – Hawaii, Hawaii, HI.

2022

1. December 8, 2022. “Type 2 Inflammation in Dermatologic Disease.” Sanofi. ADVENT. Diversity in Dermatology, National Webinar.
2. December 1, 2022. “Type 2 Inflammation and its Role in Associated Diseases.” Sanofi. ADVENT: Diversity in Dermatology, National Webinar.
3. October 23, 2022. “Early Dermatology Practice Pearls: Atopic Dermatitis.” Fall Clinical Dermatology Conference, Las Vegas, NV.
4. October 22, 2022. “Early Career Dermatology Tips and Tricks.” Panelist. Fall Clinical Dermatology Conference, Las Vegas, NV.
5. October 21, 2022. “Skin of Color: Improving Dermatologic Care for Patients with Skin of Color.” AbbVie. Fall Clinical Dermatology Conference, Las Vegas, NV. 
6. October 21, 2022. “Getting Inflamed About HS: Exploring What’s Possible.” UCB. Fall Clinical Dermatology Conference, Las Vegas, NV.
7. October 20, 2022. “The Use of Steroids in Topical Psoriasis Treatment.” Seminar-in-Depth. Fall Clinical Dermatology Conference, Las Vegas, NV.
8. October 18, 2022. “Itch and Pain: Unraveling the Symptomatic Burden of Atopic Dermatitis.” Scientific Session 5: Itch and Pain. International Society of Atopic Dermatitis Annual Meeting, Montreal, Canada.
9. October 11, 2022. “An Introduction to Prurigo Nodularis.” Type 2 Inflammatory Disease Symposium. Northwestern University. Chicago, IL. 
10. October 11, 2022. “Atopic Dermatitis in Skin of Color.” Type 2 Inflammatory Disease Symposium. Northwestern University. Chicago, IL. 
11. October 9, 2022. “Treatment Updates in Atopic Dermatitis: JAK Inhibitors.” International Seminar on Eczema Awareness, Faisalabad, Pakistan. 
12. September 29, 2022. “The Heterogeneity of Atopic Dermatitis.” HMP Global. Perspectives in Atopic Dermatitis, Virtual Meeting.
13. September 24, 2022. “Are There Strategies to Normalize Skin Barrier Function in AD?”. Sanofi and Regeneron. ADVENT: Advances in Type 2 Inflammation, Rio di Janeiro, Brazil.
14. September 24, 2022. “From Transcriptome to Clinical Practice: Patient Profiles and Treat to Target Strategy.” Sanofi and Regeneron. ADVENT: Advances in Type 2 Inflammation, Rio di Janeiro, Brazil.
15. August 25, 2022. “Updates in Hidradenitis Suppurativa.” Illinois Society of Dermatology Physician Assistants Annual Midwest Dermatology Conference, Chicago, IL.
16. August 25, 2022. “All You Need to Know About Seborrheic Dermatitis.” Illinois Society of Dermatology Physician Assistants Annual Midwest Dermatology Conference, Chicago, IL.
17. August 25, 2022. “Advancements in Vitiligo.” Illinois Society of Dermatology Physician Assistants Annual Midwest Dermatology Conference, Chicago, IL.
18. August 18, 2022. “Retirement Planning: It’s Never Too Early.” Foundation for Research and Education in Dermatology. Early Career Dermatologist Initiative, National Webinar.
19. July 27, 2022. “My Introduction to Atopic Dermatitis: Ask Me Anything.” Wayne State University Department of Dermatology Grand Rounds, Detroit, MI.
20. July 27, 2022. “The Heterogeneity of Atopic Dermatitis.” Wayne State University Department of Dermatology Grand Rounds, Detroit, MI.
21. July 2022. “JAK Inhibitors in Atopic Dermatitis.” Symposium Speaker. American Academy of Dermatology Summer Meeting, Vancouver, Canada.
22. July 2022. “The Unique Historical Burden of Vitiligo in South Asia.” Symposium Speaker. American Academy of Dermatology Summer Meeting, Vancouver, Canada.
23. July 2022. “JAK Inhibitors for Treating Eczema.” National Eczema Association Eczema Expo, Seattle, WA.
24. July 2022. “Biologic Treatments for Eczema.” National Eczema Association Eczema Expo, Seattle, WA.July 2022. “The Path to a Cure.” Panelist. National Eczema Association Eczema Expo, Seattle, WA.
25. July 2022. “Okay, You've Got 15 Minutes.” Panelist. National Eczema Association Eczema Expo, Seattle, WA.
26. June 2022. “The JAK Class Black Box Warning: The Implications for the JAK Inhibitor Drug Development Landscape for Dermatology & Beyond.” Panelist. JAK Inhibitor Drug Development Summit, Virtual Meeting.
27. June 2022. “The Road Ahead: Topicals vs Orals vs Alternative Delivery Methods.” Panelist. JAK Inhibitor Drug Development Summit, Virtual Meeting.
28. June 2022. “Factors Affecting Patient Adherence in Topical Therapies.” Fall Clinical Dermatology Conference for NPs and PAs, Scottsdale, AZ.
29. June 9, 2022. “Pruritus and Inflammatory Skin Disease.” University of North Carolina Dermatology Residency Lectureship Series, Virtual Meeting.
30. May 2022. “The Burden of Atopic Dermatitis Out-of-Pocket Healthcare Expenses in United States Children.” Oral ePoster: Clinical Research – Sociobehavioral and Health Services Research. Society of Investigative Dermatology Annual Meeting, Portland, OR.
31. May 2022. “Treatment Updates in Atopic Dermatitis.” Indiana Academy of Dermatology Spring Meeting, Indianapolis, IN.
32. May 2022. “Atopic Dermatitis Across Shades of Skin.” Indiana Academy of Dermatology Spring Meeting, Indianapolis, IN.
33. April 2022. “Emerging Topical Anti-Inflammatory Therapy.” Mini-Symposium 4: Emerging therapies in AD. Revolutionizing Atopic Dermatitis Conference, Baltimore, MD.
34. April 2022. “Healthcare Models and Related Costs from Atopic Dermatitis.” Mini-symposium 6: Healthcare models and costs for atopic dermatitis care. Revolutionizing Atopic Dermatitis Conference, Baltimore, MD.
35. March 2022. “Atopic Dermatitis Polypharmacy and Out-Of-Pocket Healthcare Expenses in the United States.” Poster Exhibit Abstract Program. American Academy of Dermatology Annual Meeting, Boston, MA.
36. March 2022. “Characteristics of the Efficacy Response Trajectory Among Patients Who Did Not Flare During the Maintenance Phase of JADE REGIMEN.” Poster Exhibit Abstract Program. American Academy of Dermatology Annual Meeting, Boston, MA.
37. February 2022. “Does Psoriasis Itch?” Diversity in Dermatology Conference, Clearwater, FL.
38. February 2022. “Dupilumab: Beyond Atopic Dermatitis.” Diversity in Dermatology Conference, Clearwater, FL.
39. February 2022. “Ocular Manifestations of Atopic Dermatitis.” Diversity in Dermatology Conference, Clearwater, FL.
40. February 2022. “Skin Pain and Inflammatory Disease.” Diversity in Dermatology Conference, Clearwater, FL.
41. January 20, 2022. “Hot Topics in Pruritus.” Practice Pearls: Pruritus in Psoriasis, Dermatology Authority, Virtual Webinar.

2021

1. December 2021. “Case-Based Discussion of the DESCRIBE-AD Framework.” Mini-Symposium 1: Clinical Phenotypes of Atopic Dermatitis. Revolutionizing Atopic Dermatitis Conference, Virtual Meeting.
2. December 2021. “Longitudinal Course of Atopic Dermatitis.” Mini-Symposium 1: Clinical Phenotypes of Atopic Dermatitis. Revolutionizing Atopic Dermatitis Conference, Virtual Meeting.
3. December 2021. “Head and Neck Dermatitis in Atopic Dermatitis.” Mini-Symposium 1: Clinical Phenotypes of Atopic Dermatitis. Revolutionizing Atopic Dermatitis Conference, Virtual Meeting.
4. August 2021. “Now Hear This: The Latest News in Prescription Treatments for Eczema.” Panel Discussion. National Eczema Association Virtual Eczema Expo, Virtual Meeting.
5. August 2021. “Addressing the Iatrogenic Burden of Atopic Dermatitis.” Focus Session Director. American Academy of Dermatology Summer Meeting, Tampa Bay, FL.
6. August 2021. “Atopic Dermatitis in Skin of Color.” Symposium Speaker. American Academy of Dermatology Summer Meeting, Tampa Bay, FL.
7. June 2021. “Update on Dupilumab Safety.” Mini-Symposium 1: Update on Atopic Dermatitis, What’s New. Revolutionizing Atopic Dermatitis Conference, Virtual Meeting.
8. May 2021. “Impact and Associations of Atopic Dermatitis Out-Of-Pocket Healthcare Expenses in the United States.” Concurrent Mini-Symposium: Patient Population Research. Society of Investigative Dermatology Annual Meeting, Virtual Meeting.

Dr. Chovatiya is closely involved in the education and mentorship of medical students, residents, and fellows. This mentorship takes many forms and can include clinical, research, and career guidance. Many of his mentees have gone on to match into dermatology residency, pursue advanced medical training, or transition to research-based careers. Recent mentees of Dr. Chovatiya have included trainees from institutions across the United States:

Albert Einstein University

Brown University

Columbia University

Geisinger Commonwealth School of Medicine

Loyola University

Northwestern University

Rosalind Franklin University of Medicine and Science

University of California Irvine

University of California San Francisco

University of Cincinnati

University of Illinois Chicago

University of Louisville

University of Miami

University of Minnesota

University of Wisconsin

Yale University